Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × surufatinib × Endocrine × Clear all

Status

Completed 4 Unknown 3 Recruiting 3 Terminated 2 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Ga(III)-DOTATOC 2 3-Iodobenzylguanidine 2 surufatinib 1 pegfilgrastim 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 Vorinostat 1 Potassium Iodide 1 Granulocyte Colony-Stimulating Factor 1 Gallium-68 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04814732 2024-04-12

Expanded Access Program of Surufatinib

Hutchmed

No longer available

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡